TY - JOUR
T1 - Issues related to pregnancy, pregnancy prevention and abortion in the context of the COVID-19 pandemic
T2 - A WHO qualitative study protocol
AU - Cecatti, Jose Guilherme
AU - Bahamondes, Luis
AU - Ali, Moazzam
AU - Alangea, Deda Ogum
AU - Brizuela, Vanessa
AU - Nahyuha Chomi, Eunice
AU - Kouanda, Seni
AU - Karmaliani, Rozina
AU - Ladak, Laila
AU - Lumbiganon, Pisake
AU - Emefa, Modey
AU - Jen, Sothornwit
AU - Kuganantham, Hamsadvani
AU - Kim, Caron
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ.
PY - 2022/10/6
Y1 - 2022/10/6
N2 - Introduction WHO has generated standardised clinical and epidemiological research protocols to address key public health questions for SARS-CoV-2 (COVID-19) pandemic. We present a standardised protocol with the aim to fill a gap in understanding the needs, attitudes and practices related to sexual and reproductive health in the context of COVID-19 pandemic, focusing on pregnancy, pregnancy prevention and abortion. Methods and analysis plan This protocol is a prospective qualitative research, using semi-structured interviews with at least 15 pregnant women at different gestational ages and after delivery, 6 months apart from the first interview. At least 10 partners, 10 non-pregnant women and 5 healthcare professionals will be interviewed once during the course of the research. Higher number of subjects may be needed if a saturation is not achieved with these numbers. Data collection will be performed in a standardised way by skilled trained interviewers using written notes or audio-record of the interview. The data will be explored using the thematic content analysis and the researchers will look for broad patterns, generalisations or theories from these categories. Ethics and dissemination The current protocol was first technically assessed and approved by the WHO scientific committee and then approved by its ethics review committee as a guidance document. It is expected that each country/setting implementing such a generic protocol adapted to their conditions also obtain local ethical approval. Comments for the user's consideration are provided the document, as the user may need to modify methods slightly because of the local context in which this study will be carried out.
AB - Introduction WHO has generated standardised clinical and epidemiological research protocols to address key public health questions for SARS-CoV-2 (COVID-19) pandemic. We present a standardised protocol with the aim to fill a gap in understanding the needs, attitudes and practices related to sexual and reproductive health in the context of COVID-19 pandemic, focusing on pregnancy, pregnancy prevention and abortion. Methods and analysis plan This protocol is a prospective qualitative research, using semi-structured interviews with at least 15 pregnant women at different gestational ages and after delivery, 6 months apart from the first interview. At least 10 partners, 10 non-pregnant women and 5 healthcare professionals will be interviewed once during the course of the research. Higher number of subjects may be needed if a saturation is not achieved with these numbers. Data collection will be performed in a standardised way by skilled trained interviewers using written notes or audio-record of the interview. The data will be explored using the thematic content analysis and the researchers will look for broad patterns, generalisations or theories from these categories. Ethics and dissemination The current protocol was first technically assessed and approved by the WHO scientific committee and then approved by its ethics review committee as a guidance document. It is expected that each country/setting implementing such a generic protocol adapted to their conditions also obtain local ethical approval. Comments for the user's consideration are provided the document, as the user may need to modify methods slightly because of the local context in which this study will be carried out.
KW - COVID-19
KW - qualitative research
KW - reproductive medicine
UR - http://www.scopus.com/inward/record.url?scp=85139361256&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2022-063317
DO - 10.1136/bmjopen-2022-063317
M3 - Article
C2 - 36202583
AN - SCOPUS:85139361256
SN - 2044-6055
VL - 12
JO - BMJ Open
JF - BMJ Open
IS - 10
M1 - e063317
ER -